NeuroOne Medical Technologies Corporation NMTC

Company Overview

NeuroOne Medical Technologies Corporation is a U.S.-based medical technology company focused on developing and commercializing minimally invasive diagnostic and therapeutic technologies for neurological disorders. The company operates within the neurotechnology, medical device, and neurosurgical industries, with a primary emphasis on electrophysiology, epilepsy monitoring, brain-computer interface applications, and therapeutic neuromodulation. Its core products are thin-film electrode technologies designed for recording, monitoring, and stimulation of neural activity in the brain and spinal cord. Revenue generation has historically been driven by product development agreements, commercialization activities, and medical device sales associated with its electrode platforms.

The company’s primary offerings include its Evo cortical and sEEG electrode systems used for epilepsy diagnostics and intraoperative monitoring, along with emerging stimulation and ablation technologies. NeuroOne positions itself through proprietary thin-film technology intended to improve flexibility, precision, and minimally invasive access compared with conventional electrodes. The company was founded in 2009 and later became publicly traded through a reverse merger transaction. Since inception, it has evolved from a development-stage neurotechnology company into a commercially focused medical device business pursuing FDA-cleared products and strategic clinical expansion.